What Is Cryotherapy?
Cryotherapy, also known clinically as cryosurgery or cryoablation, is a specialized medical procedure that utilizes extreme cold to cause targeted cellular destruction in diseased tissue. In clinical settings, this minimally invasive technique involves introducing thin metal probes directly into or adjacent to the target area. The probes circulate a gas that rapidly freezes the nearby tissue, inducing necrosis, and is commonly employed when traditional open surgery may be unfeasible or undesirable. While the term "cryotherapy" is broad, its use in ophthalmology requires precise, controlled application to establish therapeutic effect.
Link to This Resource Page
Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
To display this...
Cryotherapy, also known clinically as cryosurgery or cryoablation, is a specialized medical procedure that utilizes extreme cold to cause targeted cellular destruction in diseased tissue. In clinical settings, this minimally invasive technique involves introducing thin metal probes directly into or adjacent to the target area. The probes circulate a gas that rapidly freezes the nearby tissue, inducing necrosis, and is commonly employed when traditional open surgery may be unfeasible or undesirable. While the term "cryotherapy" is broad, its use in ophthalmology requires precise, controlled application to establish therapeutic effect.
read more about cryotherapy ...
Copy HTML
Copied!
Is Cryotherapy Good For Eyes?
The benefit of cryotherapy to the eyes relies entirely upon the context of its application. When performed by a licensed ophthalmologist (a procedure known as cryopexy), targeted cryotherapy is an established and effective tool for treating precise pathologies. However, non-medical, systemic practices, such as Whole Body Cryotherapy (WBC), carry documented risks to ocular health. WBC involves standing in a chamber cooled to temperatures as low as minus 300 degrees Fahrenheit, and its broad health benefits remain unproven and unapproved by the Food and Drug Administration (FDA). The exposure of the eyes to these extreme temperatures and cryogenic gases poses documented hazards, including eye injuries and frostbite.
When applied medically, the controlled destructive nature of cryotherapy is leveraged therapeutically. The procedure intentionally causes cellular damage through osmotic stress, ice crystal formation, and vascular stasis, leading to localized tissue necrosis. This mechanism allows for highly successful elimination of localized problems, such as aberrant lashes, achieving effective results in 90% of treated lids. Similarly, the application of cryopexy helps prevent the progression of severe retinopathy in infants, reinforcing its value as a specialized, clinical treatment.
What Is Cryotherapy In Ophthalmology Used For?
In ophthalmology, the procedure is most commonly used as cryopexy to treat disorders of the retina. This technique is employed externally (transconjunctivally) to repair retinal tears by inducing a therapeutic scar that seals the break, thereby securing the retina to the underlying support tissue and preventing progressive detachment. It is also employed in pediatric ophthalmology for treating Retinopathy of Prematurity (ROP), where studies show that cryotherapy helps prevent the progression of severe ROP (Stage 3 plus disease and early Stage 4A) to the advanced, blinding stages.
Beyond the retina, cryosurgery addresses specific pathologies affecting the eyelids and ocular surface. For instances of trichiasis (misdirected lashes), cryosurgery is often considered the most effective method available for achieving permanent elimination. The treatment targets the hair follicle cells using freezing to achieve tissue necrosis. Cryotherapy may also be used for ocular surface conditions, where the rapid freeze/slow thaw technique is employed to destroy the microvasculature associated with the disease.
Are There Any Benefits To Cryotherapy?
A primary benefit of targeted cryotherapy is its ability to create a strong, stabilizing adhesion in the retina. For premature infants suffering from severe ROP, this treatment provides a functional benefit, stopping the disease progression and helping many treated children achieve functional vision of 6/60 or better. For patients with acute retinal tears, early application of cryopexy improves vision and stabilizes the affected area in the majority of cases.
Cryotherapy provides a high degree of technical reliability in surgical contexts. For example, in the complex surgical repair of primary Rhegmatogenous Retinal Detachment (RRD) involving pars plana vitrectomy, analysis shows that the anatomical success rate achieved by cryotherapy (87%) is statistically comparable to that achieved by endolaser retinopexy (82%). This confirms that cryopexy remains a functionally reliable tool for securing the retina, and its high success rate in localized treatments, such as lash ablation, further supports its ongoing use.
When Should You Do Cryotherapy?
Cryotherapy is indicated primarily when a surgeon needs to create a permanent, strong adhesion in the retina that is difficult to access via internal methods. It is used to seal peripheral retinal tears and detachments and remains critical for treating specific anterior segment conditions, such as the effective elimination of trichiasis (misdirected lashes). In the specialized field of pediatric ophthalmology, it is utilized to stabilize the retina and halt the progression of severe Retinopathy of Prematurity.
While laser photocoagulation is the common choice when visualization is good, cryotherapy may be selected when media clarity is poor, such as when significant vitreous hemorrhage or cataract obscures the view necessary for laser application. The external application of cryopexy makes it particularly valuable for lesions located very far forward in the periphery that are technically restricted from being reached by internally applied laser probes. Clinical outcomes demonstrate that cryotherapy is an equivalent technique to endolaser in securing high anatomical success rates for surgical retinal detachment repair.